China Prebiotics Market Size & Outlook, 2026-2034

China Prebiotics Market Insights

As highlighted in Deep Market Insights analysis, the China Prebiotics Market, worth USD 1419.16 Million in 2025, is forecasted to achieve USD 3647.58 Million by 2034.
The China market is anticipated to grow at a CAGR of 10.97% during the period 2026–2034.
By 2025, Inulin represented the largest share of the By Type market size.
Inulin is expected to remain the key growth driver within By Type, registering the fastest CAGR during the forecast period.

China accounted for 13.14% of the global Prebiotics Market size in 2025.
By 2034, United States is expected to remain the top global market in terms of size.
Within Asia Pacific, China is forecasted to dominate the regional Prebiotics Market size by 2034.
China will be the fastest-growing market in Asia Pacific, projected to achieve USD 3621.44 Million by 2034.

Report Scope	Details
Base Year for Study	2025
Study Period	2022-2034
Historical Period	2022-2024
Forecast Period	2026-2034
Market Size In 2025	USD 1419.16 Million
Market Size In 2034	USD 3647.58 Million
Largest segment	Inulin
Units	Revenue in USD Million
CAGR	10.97% (2026-2034)
Segmnetation Covered
By Type	Inulin Fructooligosaccharides Galactooligosaccharides Resistant starch
By Source	Plant-based Microbial Synthetic Animal-based
By Application	Food & beverages Nutraceuticals Animal feed Pharmaceuticals
By Form	Powder Liquid Capsules Tablets
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

By Type	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Inulin	XX.x	XX.x	XX.x	699.22	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Fructooligosaccharides	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Galactooligosaccharides	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Resistant starch	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

By Source	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Plant-based	XX.x	XX.x	XX.x	633.23	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Microbial	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Synthetic	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Animal-based	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

By Application	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Food & beverages	XX.x	XX.x	XX.x	659.06	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Nutraceuticals	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Animal feed	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Pharmaceuticals	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

By Form	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Powder	XX.x	XX.x	XX.x	637.91	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Liquid	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Capsules	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Tablets	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x